“The Impact of Brexit on Pharmacovigilance”
With PrimeVigilance experts
Dr. Marcela Fialova and Dr. Jana Hyankova.
PrimeVigilance, an Ergomed Group company,
employs over 700 highly qualified
professionals and offers flexible
resourcing strategies solutions around the globe.
PrimeVigilance Announces Provision of
Clinical Safety Services for COVID-19
Clinical Trial Program.
We have a proven track record in Pharmacovigilance,
managing Medical Information queries and now
bring our partners Pharmacoepidemology & Risk
Management solutions.
Providing regulatory services and clinical
development consultancy throughout the entire
life cycle of medical products with an international
team of qualified regulatory experts.
PrimeVigilance covers the entire product life cycle, assisting clients with the effective management of their drug safety information, and offering expert consulting services from former regulators and opinion leaders.
Offering optimal approaches to life cycle benefit-risk management by providing systematic risk minimisation and faster insights into the safety and effectiveness of drugs.
PrimeVigilance is a quality resource for concise, timely and accurate communication with highly trained, industry experienced healthcare professionals providing Medical Information
The Impact of Brexit on Pharmacovigilance
Featured Speaker:
In partnership with our clients, PrimeVigilance is committed to improving patient health.
Our success begins with our people. Build your career in one of the most rewarding fields in the world.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)
USA
Croatia
USA
Germany
Czech Republic
Serbia
Poland
This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.